"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Transscatheter aortic valve replacement is a novel way to replace ... size of the aortic annulus in order to determine the correct transcatheter valve size. The iliofemoral arterial system is ...

Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

4C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

The global market for heart valve repair and replacement devices is projected to rise by $2.58b by 2028 at a compound annual growth rate of 7.08%, said Technavio.